Takeda forms drug discovery alliance with SGC
Takeda’s contribution raises the SGC’s funds to $50m, strengthening the pre-competitive approach to drug research. The SGC identifies and maps the three-dimensional structure of human proteins, which are
Kyowa Kirin subsidiary Kyowa Kirin EMEA has received approval from the European Commission (EC) to expand the use of Crysvita (burosumab) for treating X-linked hypophosphataemia (XLH) in infants aged one month to one year across the EU and European Economic Area.
Par’s initial shipments will comprise generically-labeled presentations of the Provigil product. Modafinil, a wakefulness-prompting agent for oral administration, indicated to improve wakefulness in adult patients with excessive sleepiness